Reports
Sale
Global Infectious Disease Molecular Diagnostics Market Share, Forecast, Analysis, Trends: By Product: Instruments, Reagents, Services; By Technology: Polymerase Chain Reaction (PCR), In Situ Hybridisation, Others; By Application; By End Use; Regional Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2023-2028
Global Infectious Disease Molecular Diagnostics Market Outlook
The global market size for infectious disease molecular diagnostics reached a value of more than USD 33.68 billion in 2021. The global infectious disease molecular diagnostics market is expected to grow at a CAGR of 3.20% between 2023 and 2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Infectious disease molecular diagnostics are the tests used to discover newly emerging strains of infectious diseases and identifying resistant organisms that are correlated to the disease and its severity. These tests start by collecting of DNA or RNA from human cells and then analysing the sequence that could be the reason for the start of a specific infectious disease. Gene amplification by PCR is used most often in the clinical laboratories as a molecular diagnostic method.
- Awareness towards medicines and preventive care for infectious diseases are increasing the demand for the molecular diagnoses which will also enhance the growth of the market.
- New molecular test techniques and platforms such as real time-PCR platforms, point-of-care molecular testing, and various other innovative developments are gaining the trust of the people which is ultimately helping in the growth of the market.
- The like lack of skilled labour and high infrastructure cost may pose challenges to the growth of the infectious disease molecular diagnostics market in the forecast period.
Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the infectious disease molecular diagnostics market can be segmented into instruments, reagents, and services. On the basis of technology, it can be divided into polymerase chain reaction (PCR), in situ hybridisation, isothermal nucleic acid amplification technology (INAAT), chips and microarrays, mass spectrometry, sequencing, transcription mediated amplification, and others.
By application the market is segmented into respiratory diseases, tuberculosis, meningitis, gastrointestinal tract infections, HPV, sexually transmitted infections, sepsis, drug resistance diseases, and others. Based on end use, the market is divided into hospitals, clinics, diagnostic laboratories, and research institutes. The regional markets can be categorised into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global infectious disease molecular diagnostics market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Becton, Dickinson and Company
- bioMérieux SA
- Qiagen GmbH
- F. Hoffmann-La Roche Ltd
- Abbot Laboratories
- Danaher Corporation
- Others
Market Share by Product
The reagent segment of the market infectious disease molecular diagnostics based on product is leading as they help in rapid and sensitive amplification of the RNA and DNA which facilitates discovery of faster results by speeding up processing. It is expected to dominate the market in the future as well. This is due to the increase in adoption of point-of-care testing techniques.
Market Share by Region
The Asia Pacific holds a significant segment of the infectious disease molecular diagnostics market as a result of vast prevalence of infectious diseases, increasing geriatric population, and rise in medicine expenditure. Advanced technologies are increasingly adopted and healthcare infrastructure is improving in the Asia Pacific region. Healthcare providers and governments are boosting the use of specialised diagnostic techniques which is ultimately contributing to the growth of the overall market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Becton, Dickinson and Company founded in 1897 has its headquarter in New Jersey, United States. It is a medical technology company that believes in improving the health of individuals worldwide by making innovative and better medical discoveries.
bioMérieux SA is a French biotechnology company which was established in 1963 and is headquartered in France, with branches in 44 countries. They have distributors globally who help their products reach more than 160 countries.
Qiagen GmbH was founded in 1984 and has its operational headquarters in Hilden, Germany while its corporate headquarters are in Venlo, Netherlands. It is a biotechnology company which provides molecular samples across the world to help gain insights.
Other market players include F. Hoffmann-La Roche Ltd, Abbot Laboratories, Danaher Corporation, and Others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Infectious Disease Molecular Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Global Infectious Disease Molecular Diagnostics Historical Market (2018-2022)
8.3 Global Infectious Disease Molecular Diagnostics Market Forecast (2023-2028)
8.4 Global Infectious Disease Molecular Diagnostics Market by Product
8.4.1 Instruments
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Reagents
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Services
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.5 Global Infectious Disease Molecular Diagnostics Market by Technology
8.5.1 Polymerase Chain Reaction (PCR)
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 In Situ Hybridisation
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Chips and Microarrays
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Mass Spectrometry
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2022)
8.5.5.3 Forecast Trend (2023-2028)
8.5.6 Sequencing
8.5.6.1 Market Share
8.5.6.2 Historical Trend (2018-2022)
8.5.6.3 Forecast Trend (2023-2028)
8.5.7 Transcription Mediated Amplification
8.5.7.1 Market Share
8.5.7.2 Historical Trend (2018-2022)
8.5.7.3 Forecast Trend (2023-2028)
8.5.8 Others
8.6 Global Infectious Disease Molecular Diagnostics Market by Application
8.6.1 Respiratory Diseases
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Tuberculosis
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Meningitis
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Gastrointestinal Tract Infections
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 HPV
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2022)
8.6.5.3 Forecast Trend (2023-2028)
8.6.6 Sexually Transmitted Infections
8.6.6.1 Market Share
8.6.6.2 Historical Trend (2018-2022)
8.6.6.3 Forecast Trend (2023-2028)
8.6.7 Sepsis
8.6.7.1 Market Share
8.6.7.2 Historical Trend (2018-2022)
8.6.7.3 Forecast Trend (2023-2028)
8.6.8 Drug Resistance Diseases
8.6.8.1 Market Share
8.6.8.2 Historical Trend (2018-2022)
8.6.8.3 Forecast Trend (2023-2028)
8.6.9 Others
8.7 Global Infectious Disease Molecular Diagnostics Market by End Use
8.7.1 Hospitals
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Clinics
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Diagnostic Laboratories
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Research Institutes
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.8 Global Infectious Disease Molecular Diagnostics Market by Region
8.8.1 North America
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2018-2022)
8.8.1.3 Forecast Trend (2023-2028)
8.8.2 Europe
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2018-2022)
8.8.2.3 Forecast Trend (2023-2028)
8.8.3 Asia Pacific
8.8.3.1 Market Share
8.8.3.2 Historical Trend (2018-2022)
8.8.3.3 Forecast Trend (2023-2028)
8.8.4 Latin America
8.8.4.1 Market Share
8.8.4.2 Historical Trend (2018-2022)
8.8.4.3 Forecast Trend (2023-2028)
8.8.5 Middle East and Africa
8.8.5.1 Market Share
8.8.5.2 Historical Trend (2018-2022)
8.8.5.3 Forecast Trend (2023-2028)
9 North America Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Becton, Dickinson and Company
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 bioMérieux SA
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Qiagen GmbH
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 F. Hoffmann-La Roche Ltd
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Abbott Laboratories
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Danaher Corporation
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Figures and Tables
1. Global Infectious Disease Molecular Diagnostics Market: Key Industry Highlights, 2018 and 2028
2. Global Infectious Disease Molecular Diagnostics Historical Market: Breakup by Product (USD Million), 2018-2022
3. Global Infectious Disease Molecular Diagnostics Market Forecast: Breakup by Product (USD Million), 2023-2028
4. Global Infectious Disease Molecular Diagnostics Historical Market: Breakup by Technology (USD Million), 2018-2022
5. Global Infectious Disease Molecular Diagnostics Market Forecast: Breakup by Technology (USD Million), 2023-2028
6. Global Infectious Disease Molecular Diagnostics Historical Market: Breakup by Application (USD Million), 2018-2022
7. Global Infectious Disease Molecular Diagnostics Market Forecast: Breakup by Application (USD Million), 2023-2028
8. Global Infectious Disease Molecular Diagnostics Historical Market: Breakup by End Use (USD Million), 2018-2022
9. Global Infectious Disease Molecular Diagnostics Market Forecast: Breakup by End Use (USD Million), 2023-2028
10. Global Infectious Disease Molecular Diagnostics Historical Market: Breakup by Region (USD Million), 2018-2022
11. Global Infectious Disease Molecular Diagnostics Market Forecast: Breakup by Region (USD Million), 2023-2028
12. North America Infectious Disease Molecular Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2022
13. North America Infectious Disease Molecular Diagnostics Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Europe Infectious Disease Molecular Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2022
15. Europe Infectious Disease Molecular Diagnostics Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Asia Pacific Infectious Disease Molecular Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2022
17. Asia Pacific Infectious Disease Molecular Diagnostics Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Latin America Infectious Disease Molecular Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2022
19. Latin America Infectious Disease Molecular Diagnostics Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Middle East and Africa Infectious Disease Molecular Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2022
21. Middle East and Africa Infectious Disease Molecular Diagnostics Market Forecast: Breakup by Country (USD Million), 2023-2028
22. Global Infectious Disease Molecular Diagnostics Market Structure
Key Questions Answered in the Report
The global market size for infectious disease molecular diagnostics reached a value of more than USD 33.68 billion in 2021.
The global market for infectious disease molecular diagnostics is expected to grow at a CAGR of 3.20% between 2023 and 2028.
Increase in geriatric population and surging use of molecular diagnostic to detect infectious diseases are the major market drivers.
The key trends of the market are increasing awareness programmes about importance of targeted medication and treatment and development of new molecular testing techniques.
The regional markets can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
Key players in the global infectious disease molecular diagnostics market are Becton, Dickinson and Company, bioMérieux SA, Qiagen GmbH, F. Hoffmann-La Roche Ltd, Abbot Laboratories, and Danaher Corporation, among others.
Infectious disease molecular diagnostics refers to tests that are used to discover newly emerging strains of infectious diseases and identify resistant organisms that are correlated to the disease and its severity.
The tests start by collecting of DNA or RNA from human cells and then analysing the sequence that could be the reason for the start of a specific infectious disease.
The market for infectious disease molecular diagnostics is segmented based on product, technology, application, end use and region.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$4199$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER